CN Stock MarketDetailed Quotes

Shenzhen Bioeasy Biotechnology (300942)

Watchlist
  • 7.35
  • -0.16-2.13%
Market Closed May 20 15:00 CST
2.98BMarket Cap432.35P/E (TTM)

Shenzhen Bioeasy Biotechnology (300942) Balance Sheet

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Assets
Current assets
Money funds
-1.72%412.01M
33.89%392.84M
79.58%449.8M
2.76%397.22M
-16.21%419.23M
-39.10%293.4M
-61.38%250.47M
68.73%386.56M
135.94%500.35M
94.68%481.75M
Transactional financial assets
15.63%187.64M
-22.32%235.3M
-56.25%145.05M
-41.22%139.51M
34.87%162.27M
152.37%302.92M
--331.55M
355.12%237.36M
299.73%120.32M
--120.03M
Notes receivable and accounts receivable
25.63%102.74M
18.30%111.33M
20.91%100.41M
16.22%90.15M
35.22%81.78M
23.59%94.11M
19.87%83.05M
26.62%77.57M
8.64%60.48M
-9.22%76.15M
-Notes receivable
2,940.37%944.19K
2,147.80%1.12M
--681.86K
--220.94K
--31.06K
--50K
----
----
----
----
-Accounts receivable
24.52%101.8M
17.17%110.21M
20.09%99.73M
15.94%89.93M
35.17%81.75M
23.52%94.06M
20.32%83.05M
26.67%77.57M
8.75%60.48M
-9.22%76.15M
Other receivables (including interest and dividends)
8.16%5.12M
-24.08%4.4M
-57.35%4.13M
-58.92%5.2M
-65.10%4.73M
-43.56%5.8M
-49.17%9.68M
-26.02%12.65M
-28.96%13.55M
-32.28%10.27M
-Other receivable
----
-24.08%4.4M
----
-58.92%5.2M
----
-43.56%5.8M
----
-26.02%12.65M
----
-32.28%10.27M
Advance payment
94.26%16.37M
85.50%9.1M
-61.30%4.77M
-57.05%5.47M
-13.65%8.43M
-17.76%4.91M
-9.46%12.32M
-41.54%12.73M
-46.24%9.76M
-56.82%5.97M
Inventories
52.24%62.28M
35.48%54.77M
49.56%57.91M
28.42%52.71M
16.97%40.91M
28.51%40.43M
-38.84%38.72M
-39.93%41.05M
-58.04%34.97M
-68.73%31.46M
Receivable financing
----
----
----
----
----
----
--555.04K
--590.51K
--397.76K
-66.67%50K
Other current assets
-9.39%12.1M
0.11%10.07M
80.21%12.53M
54.92%10.78M
35.83%13.35M
-16.15%10.06M
-18.96%6.95M
-92.50%6.96M
-93.59%9.83M
-94.38%11.99M
Total current assets
9.21%798.26M
8.81%817.81M
5.74%775.37M
-9.45%702.23M
-2.50%730.93M
1.89%751.62M
-10.83%733.31M
42.93%775.47M
31.12%749.65M
9.38%737.67M
Non Current assets
Other equity investment
--5M
--5M
----
----
----
----
----
----
----
----
Long-term equity investment
-35.06%64.92M
-22.02%78.52M
-17.98%84.48M
-9.18%96.97M
-30.11%99.96M
-30.64%100.69M
-46.22%103M
-44.65%106.77M
-25.53%143.02M
-25.84%145.18M
Fixed assets
----
58.63%576.01M
----
846.67%501.68M
----
535.90%363.11M
----
-40.22%52.99M
----
-32.01%57.1M
Constru in process
----
-98.87%2.26M
----
-82.84%70.9M
----
-43.98%199.79M
----
66.62%413.14M
----
86.85%356.63M
Intangible assets
-4.88%36.86M
-4.82%37.35M
-4.85%37.79M
-4.76%38.27M
-5.58%38.76M
-5.19%39.24M
-3.72%39.71M
-3.54%40.18M
-2.10%41.05M
-2.38%41.39M
Long deferred expense
-34.78%1.14M
-67.72%541.07K
391.75%2.8M
177.38%1.72M
-0.42%1.74M
-12.98%1.68M
-95.38%570.16K
-91.41%621.09K
-84.08%1.75M
-86.53%1.93M
Deferred tax assets
1,007.22%9.74M
8,810.98%7.05M
110.58%2.9M
-43.70%1.32M
-71.73%879.98K
-97.41%79.08K
-92.86%1.38M
-91.95%2.35M
-84.72%3.11M
-79.49%3.06M
Usufruct assets
----
----
----
----
----
----
----
-98.55%339.3K
-80.11%8.9M
-74.30%12.8M
Other non current assets
----
----
-51.39%972K
209.58%7.05M
105.77%957.41K
62.20%957.41K
-41.23%2M
-76.76%2.28M
-98.61%465.28K
-96.32%590.28K
Total non current assets
-3.15%689.71M
0.17%706.73M
9.41%706.19M
16.04%717.93M
10.16%712.14M
14.04%705.55M
-1.15%645.45M
-3.45%618.68M
2.43%646.48M
1.75%618.67M
Total assets
3.11%1.49B
4.62%1.52B
7.46%1.48B
1.86%1.42B
3.36%1.44B
7.43%1.46B
-6.55%1.38B
17.82%1.39B
16.06%1.4B
5.76%1.36B
Liabilities
Current liabilities
Short term loan
--11M
--21M
----
----
----
----
----
----
----
----
Notes payable and accounts payable
-12.59%44.77M
24.15%72.96M
20.48%74.84M
-23.10%57.88M
-34.83%51.22M
-24.03%58.76M
27.31%62.12M
28.14%75.27M
24.63%78.59M
18.81%77.35M
-Accounts payable
-12.59%44.77M
24.15%72.96M
20.48%74.84M
-23.10%57.88M
-34.83%51.22M
-24.03%58.76M
27.31%62.12M
28.14%75.27M
24.63%78.59M
18.81%77.35M
Contract liabilities
-26.74%14.18M
-31.25%17.18M
-7.46%16.86M
-5.89%17.31M
7.12%19.36M
34.04%24.99M
-44.82%18.22M
-41.63%18.4M
-42.41%18.07M
-72.01%18.65M
Advance receipts
-56.69%413.84K
-37.43%68.61K
--431.05K
--693.05K
--955.55K
--109.65K
----
----
----
----
Salaries payable
22.93%15.61M
15.46%21.59M
-8.99%17.62M
-4.49%16.51M
-7.26%12.7M
-2.28%18.7M
-3.58%19.36M
-8.20%17.29M
-16.85%13.69M
-39.20%19.14M
Taxs payable
44.26%3.72M
607.92%5.6M
148.57%1.44M
73.46%717.11K
73.36%2.58M
-34.85%790.69K
-65.35%578.33K
-95.08%413.41K
-80.52%1.49M
-79.06%1.21M
Other payable (including interest and dividends)
3.99%3.95M
51.20%6.69M
154.90%5.1M
-37.27%3.5M
-15.00%3.8M
-5.42%4.42M
-74.99%2M
-5.03%5.57M
42.45%4.47M
12.89%4.68M
-Other payable
----
51.20%6.69M
----
-37.27%3.5M
----
-5.42%4.42M
----
-5.03%5.57M
----
12.89%4.68M
Non current liabilities due within one year
-65.58%13.98M
-67.42%13.55M
-15.08%31.99M
-72.23%11.03M
198.52%40.62M
181.94%41.6M
94.47%37.67M
96.67%39.71M
-43.72%13.61M
-37.94%14.75M
Other current liabilities
-25.65%1.84M
-18.72%2.07M
15.47%2.03M
12.03%1.84M
150.11%2.48M
121.64%2.55M
-2.57%1.76M
-5.90%1.64M
-42.25%991.37K
-60.04%1.15M
Total current liabilities
-18.13%109.46M
5.76%160.7M
6.07%150.3M
-30.95%109.48M
2.14%133.7M
10.98%151.96M
6.76%141.7M
9.10%158.53M
-11.34%130.9M
-31.46%136.93M
Current liabilities
Long term loan
4.83%174.52M
-4.44%155.97M
44.18%160.53M
45.51%163.94M
12.66%166.48M
62.68%163.22M
-7.71%111.35M
9.60%112.66M
162.78%147.77M
78.14%100.33M
Bonds payable
-2.41%261.99M
-2.33%257.03M
-3.32%251.96M
7.16%273.81M
7.24%268.46M
7.22%263.17M
8.77%260.61M
--255.51M
--250.34M
--245.45M
Estimate liabilities
0.00%2.08M
0.00%2.08M
0.00%2.08M
0.00%2.08M
-31.21%2.08M
-31.21%2.08M
0.00%2.08M
0.00%2.08M
45.36%3.02M
45.36%3.02M
Long term deferred income
573.72%40.5M
532.19%41.09M
-31.99%6.33M
-67.17%5.43M
-64.74%6.01M
-60.71%6.5M
-55.41%9.31M
-24.99%16.54M
-23.13%17.05M
-18.61%16.54M
Lease liabilities
----
----
----
----
----
----
----
----
-89.33%3.62M
-86.40%5.34M
Total non current liabilities
8.14%479.08M
4.87%456.16M
9.80%420.9M
15.11%445.26M
5.03%443.03M
17.34%434.97M
-2.76%383.34M
174.60%386.8M
268.31%421.8M
214.22%370.68M
Total liabilities
2.05%588.54M
5.10%616.87M
8.79%571.21M
1.72%554.73M
4.35%576.73M
15.62%586.92M
-0.36%525.04M
90.57%545.33M
110.82%552.7M
59.75%507.61M
Shareholders equity
Paid-in capital
0.93%405.07M
0.93%405.07M
1.05%405.07M
0.11%401.32M
0.11%401.32M
0.11%401.32M
0.00%400.87M
0.00%400.87M
0.00%400.87M
0.00%400.86M
Other equity instruments
-10.14%61.45M
-10.14%61.45M
-10.09%62.38M
-1.44%68.39M
-1.44%68.39M
-1.46%68.39M
-15.03%69.38M
--69.39M
--69.39M
--69.4M
Capital reserve funds
16.49%221.58M
16.48%221.56M
18.20%220.64M
1.91%190.22M
1.92%190.22M
1.94%190.22M
0.05%186.67M
0.04%186.65M
2.55%186.64M
4.42%186.59M
Surplus reserve funds
0.25%55.65M
0.25%55.65M
3.61%55.51M
3.61%55.51M
3.61%55.51M
3.61%55.51M
0.00%53.58M
0.00%53.58M
0.00%53.58M
0.00%53.58M
Retained profit
-0.20%149.98M
4.30%160.24M
15.68%164.66M
8.83%148.97M
14.43%150.28M
10.97%153.63M
-36.51%142.34M
-46.05%136.88M
-56.77%131.33M
-58.28%138.44M
Other composite income
-391.97%-113.46K
287.01%104.36K
-421.20%-164.03K
-117.46%-19.98K
-21.74%38.86K
-148.14%-55.8K
-97.01%51.07K
-95.64%114.46K
-92.84%49.65K
222.06%115.93K
Shareholders equity without minority interests
3.22%893.62M
4.04%904.08M
6.47%908.09M
2.00%864.39M
2.84%865.76M
2.36%869.01M
-10.09%852.89M
-5.56%847.48M
-10.53%841.86M
-12.01%848.99M
Minority interests
883.96%5.8M
190.99%3.6M
174.23%2.26M
-23.37%1.03M
-62.69%589.49K
565.74%1.24M
481.38%824.61K
764.67%1.34M
950.40%1.58M
-39.77%-265.65K
Total shareholder equity
3.82%899.42M
4.30%907.68M
6.63%910.35M
1.96%865.42M
2.72%866.35M
2.53%870.24M
-9.98%853.72M
-5.39%848.82M
-10.34%843.44M
-12.02%848.73M
Total liabilityies and equity
3.11%1.49B
4.62%1.52B
7.46%1.48B
1.86%1.42B
3.36%1.44B
7.43%1.46B
-6.55%1.38B
17.82%1.39B
16.06%1.4B
5.76%1.36B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Assets
Current assets
Money funds -1.72%412.01M33.89%392.84M79.58%449.8M2.76%397.22M-16.21%419.23M-39.10%293.4M-61.38%250.47M68.73%386.56M135.94%500.35M94.68%481.75M
Transactional financial assets 15.63%187.64M-22.32%235.3M-56.25%145.05M-41.22%139.51M34.87%162.27M152.37%302.92M--331.55M355.12%237.36M299.73%120.32M--120.03M
Notes receivable and accounts receivable 25.63%102.74M18.30%111.33M20.91%100.41M16.22%90.15M35.22%81.78M23.59%94.11M19.87%83.05M26.62%77.57M8.64%60.48M-9.22%76.15M
-Notes receivable 2,940.37%944.19K2,147.80%1.12M--681.86K--220.94K--31.06K--50K----------------
-Accounts receivable 24.52%101.8M17.17%110.21M20.09%99.73M15.94%89.93M35.17%81.75M23.52%94.06M20.32%83.05M26.67%77.57M8.75%60.48M-9.22%76.15M
Other receivables (including interest and dividends) 8.16%5.12M-24.08%4.4M-57.35%4.13M-58.92%5.2M-65.10%4.73M-43.56%5.8M-49.17%9.68M-26.02%12.65M-28.96%13.55M-32.28%10.27M
-Other receivable -----24.08%4.4M-----58.92%5.2M-----43.56%5.8M-----26.02%12.65M-----32.28%10.27M
Advance payment 94.26%16.37M85.50%9.1M-61.30%4.77M-57.05%5.47M-13.65%8.43M-17.76%4.91M-9.46%12.32M-41.54%12.73M-46.24%9.76M-56.82%5.97M
Inventories 52.24%62.28M35.48%54.77M49.56%57.91M28.42%52.71M16.97%40.91M28.51%40.43M-38.84%38.72M-39.93%41.05M-58.04%34.97M-68.73%31.46M
Receivable financing --------------------------555.04K--590.51K--397.76K-66.67%50K
Other current assets -9.39%12.1M0.11%10.07M80.21%12.53M54.92%10.78M35.83%13.35M-16.15%10.06M-18.96%6.95M-92.50%6.96M-93.59%9.83M-94.38%11.99M
Total current assets 9.21%798.26M8.81%817.81M5.74%775.37M-9.45%702.23M-2.50%730.93M1.89%751.62M-10.83%733.31M42.93%775.47M31.12%749.65M9.38%737.67M
Non Current assets
Other equity investment --5M--5M--------------------------------
Long-term equity investment -35.06%64.92M-22.02%78.52M-17.98%84.48M-9.18%96.97M-30.11%99.96M-30.64%100.69M-46.22%103M-44.65%106.77M-25.53%143.02M-25.84%145.18M
Fixed assets ----58.63%576.01M----846.67%501.68M----535.90%363.11M-----40.22%52.99M-----32.01%57.1M
Constru in process -----98.87%2.26M-----82.84%70.9M-----43.98%199.79M----66.62%413.14M----86.85%356.63M
Intangible assets -4.88%36.86M-4.82%37.35M-4.85%37.79M-4.76%38.27M-5.58%38.76M-5.19%39.24M-3.72%39.71M-3.54%40.18M-2.10%41.05M-2.38%41.39M
Long deferred expense -34.78%1.14M-67.72%541.07K391.75%2.8M177.38%1.72M-0.42%1.74M-12.98%1.68M-95.38%570.16K-91.41%621.09K-84.08%1.75M-86.53%1.93M
Deferred tax assets 1,007.22%9.74M8,810.98%7.05M110.58%2.9M-43.70%1.32M-71.73%879.98K-97.41%79.08K-92.86%1.38M-91.95%2.35M-84.72%3.11M-79.49%3.06M
Usufruct assets -----------------------------98.55%339.3K-80.11%8.9M-74.30%12.8M
Other non current assets ---------51.39%972K209.58%7.05M105.77%957.41K62.20%957.41K-41.23%2M-76.76%2.28M-98.61%465.28K-96.32%590.28K
Total non current assets -3.15%689.71M0.17%706.73M9.41%706.19M16.04%717.93M10.16%712.14M14.04%705.55M-1.15%645.45M-3.45%618.68M2.43%646.48M1.75%618.67M
Total assets 3.11%1.49B4.62%1.52B7.46%1.48B1.86%1.42B3.36%1.44B7.43%1.46B-6.55%1.38B17.82%1.39B16.06%1.4B5.76%1.36B
Liabilities
Current liabilities
Short term loan --11M--21M--------------------------------
Notes payable and accounts payable -12.59%44.77M24.15%72.96M20.48%74.84M-23.10%57.88M-34.83%51.22M-24.03%58.76M27.31%62.12M28.14%75.27M24.63%78.59M18.81%77.35M
-Accounts payable -12.59%44.77M24.15%72.96M20.48%74.84M-23.10%57.88M-34.83%51.22M-24.03%58.76M27.31%62.12M28.14%75.27M24.63%78.59M18.81%77.35M
Contract liabilities -26.74%14.18M-31.25%17.18M-7.46%16.86M-5.89%17.31M7.12%19.36M34.04%24.99M-44.82%18.22M-41.63%18.4M-42.41%18.07M-72.01%18.65M
Advance receipts -56.69%413.84K-37.43%68.61K--431.05K--693.05K--955.55K--109.65K----------------
Salaries payable 22.93%15.61M15.46%21.59M-8.99%17.62M-4.49%16.51M-7.26%12.7M-2.28%18.7M-3.58%19.36M-8.20%17.29M-16.85%13.69M-39.20%19.14M
Taxs payable 44.26%3.72M607.92%5.6M148.57%1.44M73.46%717.11K73.36%2.58M-34.85%790.69K-65.35%578.33K-95.08%413.41K-80.52%1.49M-79.06%1.21M
Other payable (including interest and dividends) 3.99%3.95M51.20%6.69M154.90%5.1M-37.27%3.5M-15.00%3.8M-5.42%4.42M-74.99%2M-5.03%5.57M42.45%4.47M12.89%4.68M
-Other payable ----51.20%6.69M-----37.27%3.5M-----5.42%4.42M-----5.03%5.57M----12.89%4.68M
Non current liabilities due within one year -65.58%13.98M-67.42%13.55M-15.08%31.99M-72.23%11.03M198.52%40.62M181.94%41.6M94.47%37.67M96.67%39.71M-43.72%13.61M-37.94%14.75M
Other current liabilities -25.65%1.84M-18.72%2.07M15.47%2.03M12.03%1.84M150.11%2.48M121.64%2.55M-2.57%1.76M-5.90%1.64M-42.25%991.37K-60.04%1.15M
Total current liabilities -18.13%109.46M5.76%160.7M6.07%150.3M-30.95%109.48M2.14%133.7M10.98%151.96M6.76%141.7M9.10%158.53M-11.34%130.9M-31.46%136.93M
Current liabilities
Long term loan 4.83%174.52M-4.44%155.97M44.18%160.53M45.51%163.94M12.66%166.48M62.68%163.22M-7.71%111.35M9.60%112.66M162.78%147.77M78.14%100.33M
Bonds payable -2.41%261.99M-2.33%257.03M-3.32%251.96M7.16%273.81M7.24%268.46M7.22%263.17M8.77%260.61M--255.51M--250.34M--245.45M
Estimate liabilities 0.00%2.08M0.00%2.08M0.00%2.08M0.00%2.08M-31.21%2.08M-31.21%2.08M0.00%2.08M0.00%2.08M45.36%3.02M45.36%3.02M
Long term deferred income 573.72%40.5M532.19%41.09M-31.99%6.33M-67.17%5.43M-64.74%6.01M-60.71%6.5M-55.41%9.31M-24.99%16.54M-23.13%17.05M-18.61%16.54M
Lease liabilities ---------------------------------89.33%3.62M-86.40%5.34M
Total non current liabilities 8.14%479.08M4.87%456.16M9.80%420.9M15.11%445.26M5.03%443.03M17.34%434.97M-2.76%383.34M174.60%386.8M268.31%421.8M214.22%370.68M
Total liabilities 2.05%588.54M5.10%616.87M8.79%571.21M1.72%554.73M4.35%576.73M15.62%586.92M-0.36%525.04M90.57%545.33M110.82%552.7M59.75%507.61M
Shareholders equity
Paid-in capital 0.93%405.07M0.93%405.07M1.05%405.07M0.11%401.32M0.11%401.32M0.11%401.32M0.00%400.87M0.00%400.87M0.00%400.87M0.00%400.86M
Other equity instruments -10.14%61.45M-10.14%61.45M-10.09%62.38M-1.44%68.39M-1.44%68.39M-1.46%68.39M-15.03%69.38M--69.39M--69.39M--69.4M
Capital reserve funds 16.49%221.58M16.48%221.56M18.20%220.64M1.91%190.22M1.92%190.22M1.94%190.22M0.05%186.67M0.04%186.65M2.55%186.64M4.42%186.59M
Surplus reserve funds 0.25%55.65M0.25%55.65M3.61%55.51M3.61%55.51M3.61%55.51M3.61%55.51M0.00%53.58M0.00%53.58M0.00%53.58M0.00%53.58M
Retained profit -0.20%149.98M4.30%160.24M15.68%164.66M8.83%148.97M14.43%150.28M10.97%153.63M-36.51%142.34M-46.05%136.88M-56.77%131.33M-58.28%138.44M
Other composite income -391.97%-113.46K287.01%104.36K-421.20%-164.03K-117.46%-19.98K-21.74%38.86K-148.14%-55.8K-97.01%51.07K-95.64%114.46K-92.84%49.65K222.06%115.93K
Shareholders equity without minority interests 3.22%893.62M4.04%904.08M6.47%908.09M2.00%864.39M2.84%865.76M2.36%869.01M-10.09%852.89M-5.56%847.48M-10.53%841.86M-12.01%848.99M
Minority interests 883.96%5.8M190.99%3.6M174.23%2.26M-23.37%1.03M-62.69%589.49K565.74%1.24M481.38%824.61K764.67%1.34M950.40%1.58M-39.77%-265.65K
Total shareholder equity 3.82%899.42M4.30%907.68M6.63%910.35M1.96%865.42M2.72%866.35M2.53%870.24M-9.98%853.72M-5.39%848.82M-10.34%843.44M-12.02%848.73M
Total liabilityies and equity 3.11%1.49B4.62%1.52B7.46%1.48B1.86%1.42B3.36%1.44B7.43%1.46B-6.55%1.38B17.82%1.39B16.06%1.4B5.76%1.36B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More